Evotec SE
EVO3.720USD
+0.030+0.81%
Close 07/22, 16:00（ET）Quotes delayed by 15 min
1.32BMarket Cap
LossP/E TTM
More Details of Evotec SE Company
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Company Info
Ticker SymbolEVO
Company nameEvotec SE
IPO dateOct 11, 1999
Founded at2019
CEODr. Christian Wojczewski
Number of employees4827
Security typeOrdinary Share
Fiscal year-endOct 11
AddressEssener Bogen 7
CityHAMBURG
Stock exchangeOMX Nordic Exchange Stockholm AB - cash
CountryGermany
Postal code22419
Phone4940560810
Websitehttps://www.evotec.com/
Ticker SymbolEVO
IPO dateOct 11, 1999
Founded at2019
Company Executives
Name
Name/Position
Position
Shareholding
Change
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Mr. Wesley Wheeler
Mr. Wesley Wheeler
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
No Data
By RegionUSD
Name
Revenue
Proportion
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
Other
37.16M
4.31%
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, Jul 13
Updated: Sun, Jul 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.54%
BlackRock Institutional Trust Company, N.A.
0.42%
DCF Advisers, LLC
0.21%
Morgan Stanley Smith Barney LLC
0.02%
Other
97.52%
Shareholders
Shareholders
Proportion
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.54%
BlackRock Institutional Trust Company, N.A.
0.42%
DCF Advisers, LLC
0.21%
Morgan Stanley Smith Barney LLC
0.02%
Other
97.52%
Shareholder Types
Shareholders
Proportion
Sovereign Wealth Fund
1.29%
Investment Advisor
0.67%
Investment Advisor/Hedge Fund
0.55%
Hedge Fund
0.02%
Research Firm
0.01%
Other
97.45%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
60
9.07M
2.55%
-923.30K
2025Q1
60
9.08M
2.56%
-923.30K
2024Q4
59
8.93M
2.52%
-1.38M
2024Q3
56
8.37M
2.36%
-3.56M
2024Q2
55
7.62M
2.15%
-2.08M
2024Q1
54
5.00M
1.41%
-5.55M
2023Q4
56
5.70M
1.61%
-517.14K
2023Q3
51
1.23M
0.35%
-5.15M
2023Q2
46
1.39M
0.39%
-4.97M
2023Q1
43
1.38M
0.39%
-5.01M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Mar 31, 2025
Wellington Management Company, LLP
1.90M
0.54%
-396.50K
-17.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.50M
0.42%
+89.47K
+6.34%
Mar 31, 2025
DCF Advisers, LLC
751.58K
0.21%
+521.71K
+226.96%
Mar 31, 2025
Morgan Stanley Smith Barney LLC
63.92K
0.02%
+6.97K
+12.23%
Mar 31, 2025
AllianceBernstein L.P.
47.65K
0.01%
+28.58K
+149.81%
Jun 30, 2024
Tower Research Capital LLC
41.19K
0.01%
+41.19K
--
Mar 31, 2025
Lighthouse Investment Partners, LLC
37.55K
0.01%
-2.26K
-5.67%
Mar 31, 2025
Morgan Stanley & Co. LLC
24.12K
0.01%
-44.85K
-65.03%
Mar 31, 2025
Aperio Group, LLC
21.17K
0.01%
-11.04K
-34.28%
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
iShares Biotechnology ETF
0.1%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
Proportion0.1%
ActivePassive International Equity ETF
Proportion0%
DFA Dimensional Intl Sustainability Core 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
